Extensive clinical experience: nonclassical 21-hydroxylase deficiency.

CONTEXT Nonclassical congenital adrenal hyperplasia (CAH) owing to steroid 21-hydroxylase deficiency (NC21OHD) is the most frequent of all autosomal recessive genetic diseases, occurring in one in 100 persons in the heterogeneous New York City population. NC21OHD occurs with increased frequency in certain ethnic groups, such as Ashkenazi Jews, in whom one in 27 express the disease. NC21OHD is underdiagnosed in both male and female patients with hyperandrogenic symptoms because hormonal abnormalities in NC21OHD are only mild to moderate, not severe as in the classical form of CAH. Unlike classical CAH, NC21OHD is not associated with ambiguous genitalia of the newborn female. MAIN OUTCOME MEASURES The hyperandrogenic symptoms include advanced bone age, early pubic hair, precocious puberty, tall stature, and early arrest of growth in children; infertility, cystic acne, and short stature in both adult males and females; hirsutism, frontal balding, polycystic ovaries, and irregular menstrual periods in females; and testicular adrenal rest tissue in males. CONCLUSIONS The signs and symptoms of hyperandrogenism are reversed with dexamethasone treatment.

[1]  M. C. Hu,et al.  A missense mutation at Ile172----Asn or Arg356----Trp causes steroid 21-hydroxylase deficiency. , 1990, The Journal of biological chemistry.

[2]  M. New,et al.  Genetic defects of steroidogenesis in premature pubarche. , 1987, The Journal of clinical endocrinology and metabolism.

[3]  P. White,et al.  HLA-linked congenital adrenal hyperplasia results from a defective gene encoding a cytochrome P-450 specific for steroid 21-hydroxylation. , 1984 .

[4]  R. Campbell,et al.  Mapping of steroid 21-hydroxylase genes adjacent to complement component C4 genes in HLA, the major histocompatibility complex in man. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[5]  J. Seidman,et al.  Two steroid 21-hydroxylase genes are located in the murine S region , 1984, Nature.

[6]  M. Vogiatzi,et al.  Treatment with growth hormone and luteinizing hormone releasing hormone analog improves final adult height in children with congenital adrenal hyperplasia. , 2005, The Journal of clinical endocrinology and metabolism.

[7]  A. Wedell,et al.  Early growth is not increased in untreated moderately severe 21‐hydroxylase deficiency , 1995, Acta paediatrica.

[8]  M. New,et al.  Nonclassic 21-Hydroxylase Deficiency in Croatia , 2004, Journal of pediatric endocrinology & metabolism : JPEM.

[9]  P. White,et al.  Cloning and expression of cDNA encoding a bovine adrenal cytochrome P-450 specific for steroid 21-hydroxylation. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[10]  P. White,et al.  Nonsense mutation causing steroid 21-hydroxylase deficiency. , 1988, The Journal of clinical investigation.

[11]  A. Moreira,et al.  Phenotype and genotype correlation of the microconversion from the CYP21A1P to the CYP21A2 gene in congenital adrenal hyperplasia. , 2003, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[12]  B. Kohn,et al.  Cryptic 21-hydroxylase deficiency in families of patients with classical congenital adrenal hyperplasia. , 1980, The Journal of clinical endocrinology and metabolism.

[13]  B. Fauser,et al.  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). , 2004, Human reproduction.

[14]  H. Luthman,et al.  Steroid 21-hydroxylase (P450c21): a new allele and spread of mutations through the pseudogene , 1993, Human Genetics.

[15]  A. Wilton,et al.  Rearrangement of 21-hydroxylase genes in disease-associated MHC supratypes , 1986, Immunogenetics.

[16]  S. Radmanović,et al.  An update on the frequency of nonclassic deficiency of adrenal 21-hydroxylase in the Yugoslav population. , 1990, Acta endocrinologica.

[17]  R. Lobo,et al.  Adult manifestation of congenital adrenal hyperplasia due to incomplete 21-hydroxylase deficiency mimicking polycystic ovarian disease. , 1980, American journal of obstetrics and gynecology.

[18]  M. New,et al.  The effect of treatment of final height in classical congenital adrenal hyperplasia (CAH). , 1986 .

[19]  M. New,et al.  "Acquired" adrenal hyperplasia with 21-hydroxylase deficiency is not the same genetic disorders as congenital adrenal hyperplasia. , 1979, The Journal of clinical endocrinology and metabolism.

[20]  D. Charron,et al.  Phenotype-genotype correlation in 56 women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. , 2001, The Journal of clinical endocrinology and metabolism.

[21]  H. Al-Ahmadie,et al.  Ovarian `Tumor' of the Adrenogenital Syndrome: The First Reported Case , 2001, The American journal of surgical pathology.

[22]  G. Chrousos,et al.  Unilateral testicular enlargement resulting from inapparent 21-hydroxylase deficiency. , 1981, The Journal of urology.

[23]  J. G. Figueiredo,et al.  Male infertility due to congenital adrenal hyperplasia: testicular biopsy findings, hormonal evaluation, and therapeutic results in three patients. , 1987, Fertility and sterility.

[24]  M. New,et al.  Growth and final height in classical and nonclassical 21-hydroxylase deficiency. , 1988, Acta paediatrica Japonica : Overseas edition.

[25]  P. A. Lee,et al.  An attenuated form of congenital virilizing adrenal hyperplasia. , 1979, The Journal of clinical endocrinology and metabolism.

[26]  M. New,et al.  Prevalence of nonclassical steroid 21-hydroxylase deficiency based on a morning salivary 17-hydroxyprogesterone screening test: a small sample study. , 1990, The Journal of clinical endocrinology and metabolism.

[27]  G. Jager,et al.  Prevalence of ovarian adrenal rest tumours and polycystic ovaries in females with congenital adrenal hyperplasia: results of ultrasonography and MR imaging , 2004, European Radiology.

[28]  P. White,et al.  Molecular genetic analysis of nonclassic steroid 21-hydroxylase deficiency associated with HLA-B14,DR1. , 1988, The New England journal of medicine.

[29]  P. A. Lee,et al.  Adult height and fertility in men with congenital virilizing adrenal hyperplasia. , 1978, The New England journal of medicine.

[30]  Y. Fujii‐Kuriyama,et al.  Aberrant splicing and missense mutations cause steroid 21-hydroxylase [P-450(C21)] deficiency in humans: possible gene conversion products. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[31]  D. London.  The Consequences of Hyperandrogenism in Young Women , 1987, Journal of the Royal Society of Medicine.

[32]  D. Cooper,et al.  Human Gene Mutation Database , 1996, Human Genetics.

[33]  Baig Ar,et al.  Sex-chromatin values in rat epithelium. , 1967 .

[34]  M. Vogiatzi,et al.  Long term outcome in adult males with classic congenital adrenal hyperplasia. , 2001, The Journal of clinical endocrinology and metabolism.

[35]  I. Schiff,et al.  Abnormal adrenal responses to adrenocorticotropic hormone in hyperandrogenic women. , 1980, Fertility and sterility.

[36]  D W Nebert,et al.  The P450 superfamily: update on new sequences, gene mapping, and recommended nomenclature. , 1991, DNA and cell biology.

[37]  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. , 2004, Fertility and sterility.

[38]  M. New,et al.  Rapid deoxyribonucleic acid analysis by allele-specific polymerase chain reaction for detection of mutations in the steroid 21-hydroxylase gene. , 1995, The Journal of clinical endocrinology and metabolism.

[39]  V. Toscano,et al.  Isolated precocious pubarche: an approach. , 1994, The Journal of clinical endocrinology and metabolism.

[40]  P. Fossati,et al.  Clinical and biological phenotypes in late-onset 21-hydroxylase deficiency. , 1986, The Journal of clinical endocrinology and metabolism.

[41]  M. Tusié-Luna,et al.  R339H and P453S: CYP21 mutations associated with nonclassic steroid 21-hydroxylase deficiency that are not apparent gene conversions. , 1992, Molecular endocrinology.

[42]  B. Kohn,et al.  Genotyping steroid 21-hydroxylase deficiency: hormonal reference data. , 1983, The Journal of clinical endocrinology and metabolism.

[43]  A. Del Maschio,et al.  Ovarian adrenal-like tissue in congenital adrenal hyperplasia. , 1998, The New England journal of medicine.

[44]  B. Dupont,et al.  CLOSE GENETIC LINKAGE BETWEEN HLA AND CONGENITAL ADRENAL HYPERPLASIA (21-HYDROXYLASE DEFICIENCY) , 1977, The Lancet.

[45]  J. Sack,et al.  Reversible male infertility in late onset congenital adrenal hyperplasia , 1991, Journal of endocrinological investigation.

[46]  D. Ferriman,et al.  Clinical assessment of body hair growth in women. , 1961, The Journal of clinical endocrinology and metabolism.

[47]  Y. Fujii‐Kuriyama,et al.  Effects of individual mutations in the P-450(C21) pseudogene on the P-450(C21) activity and their distribution in the patient genomes of congenital steroid 21-hydroxylase deficiency. , 1991, Journal of biochemistry.

[48]  S. Marynick,et al.  Androgen excess in cystic acne. , 1983, The New England journal of medicine.

[49]  C. Dacou-voutetakis,et al.  High incidence of molecular defects of the CYP21 gene in patients with premature adrenarche. , 1999, The Journal of clinical endocrinology and metabolism.

[50]  E. Ludwig.  Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex , 1977, The British journal of dermatology.

[51]  S. Oberfield,et al.  Adrenal steroidogenic function in a black and Hispanic population with precocious pubarche. , 1990, The Journal of clinical endocrinology and metabolism.

[52]  M. New,et al.  Steroid 21-hydroxylase deficiency: genotype may not predict phenotype. , 1995, The Journal of clinical endocrinology and metabolism.

[53]  M. New,et al.  Update: Prenatal Diagnosis for Congenital Adrenal Hyperplasia in 595 Pregnancies , 2003 .

[54]  M. Forest,et al.  [Final height in 69 patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency]. , 1994, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

[55]  B. Otten,et al.  Fertility in Women With Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency , 2003, Obstetrical & gynecological survey.

[56]  M. Birnbaum,et al.  The partial adrenocortical hydroxylase deficiency syndrome in infertile women. , 1979, Fertility and sterility.

[57]  M. New,et al.  Gender Development in Women with Congenital Adrenal Hyperplasia as a Function of Disorder Severity , 2006, Archives of sexual behavior.

[58]  P. White,et al.  Frequent deletion and duplication of the steroid 21-hydroxylase genes. , 1986, American journal of human genetics.

[59]  D. Anderson,et al.  ADRENAL STEROIDOGENESIS IN HIRSUTE WOMEN , 1980, Clinical endocrinology.

[60]  J. Strominger,et al.  Two genes encoding steroid 21-hydroxylase are located near the genes encoding the fourth component of complement in man. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[61]  Conway,et al.  Genotype‐phenotype analysis in late onset 21‐hydroxylase deficiency in comparison to the classical forms , 1998, Clinical endocrinology.

[62]  M. Tusié-Luna,et al.  Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. , 1992, The Journal of clinical investigation.

[63]  M. New,et al.  “Acquired” Adrenal Hyperplasia with 21-Hydroxylase Deficiency is Not the Same Genetic Disorder as Congenital Adrenal Hyperplasia , 1979 .

[64]  N. Morton,et al.  A segregation and linkage study of classical and nonclassical 21-hydroxylase deficiency. , 1988, American journal of human genetics.

[65]  M. New,et al.  Steroid disorders in children: congenital adrenal hyperplasia and apparent mineralocorticoid excess. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[66]  H. Baker,et al.  REVERSIBLE MALE INFERTILITY DUE TO CONGENITAL ADRENAL HYPERPLASIA , 1981, Clinical endocrinology.

[67]  M. Tusié-Luna,et al.  Determination of functional effects of mutations in the steroid 21-hydroxylase gene (CYP21) using recombinant vaccinia virus. , 1990, The Journal of biological chemistry.

[68]  D. Riddick,et al.  Adrenal Virilism Due to 21‐Hydroxylase Deficiency in the Postmenarchial Female , 1975, Obstetrics and gynecology.

[69]  P. White,et al.  Distribution of deletions and seven point mutations on CYP21B genes in three clinical forms of steroid 21-hydroxylase deficiency. , 1991, American journal of human genetics.

[70]  J. Honour,et al.  Carrier status for steroid 21‐hydroxylase deficiency is only one factor in the variable phenotype of acne , 1998, Clinical endocrinology.

[71]  O. Gotoh,et al.  Complete nucleotide sequence of two steroid 21-hydroxylase genes tandemly arranged in human chromosome: a pseudogene and a genuine gene. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[72]  S. Lajic,et al.  Functional analysis of two recurrent amino acid substitutions in the CYP21 gene from Italian patients with congenital adrenal hyperplasia. , 2004, The Journal of clinical endocrinology and metabolism.

[73]  S. Blethen,et al.  17-Hydroxyprogesterone responses to adrenocorticotropin in children with premature adrenarche. , 1985, The Journal of clinical endocrinology and metabolism.

[74]  R. Voutilainen,et al.  Growth of Patients with 21-Hydroxylase Deficiency: An Analysis of the Factors Influencing Adult Height , 1997, Pediatric Research.

[75]  V. Tardy,et al.  Follow-up of 68 children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: relevance of genotype for management. , 2003, The Journal of clinical endocrinology and metabolism.

[76]  M. New,et al.  Validation and clinical application of a locus-specific polymerase chain reaction- and minisequencing-based assay for congenital adrenal hyperplasia (21-hydroxylase deficiency). , 2005, The Journal of molecular diagnostics : JMD.

[77]  K. Belt,et al.  The structural basis of the multiple forms of human complement component C4 , 1984, Cell.

[78]  P. Claman.  Men at risk: occupation and male infertility. , 2004, Fertility and sterility.

[79]  M. Tusié-Luna,et al.  Mutations in Steroid 21‐Hydroxylase (CYP21) , 1994, Human mutation.

[80]  M. Tusié-Luna,et al.  A mutation (Pro-30 to Leu) in CYP21 represents a potential nonclassic steroid 21-hydroxylase deficiency allele. , 1991, Molecular endocrinology.

[81]  P. White,et al.  Mutation in the CYP21B gene (Ile-172----Asn) causes steroid 21-hydroxylase deficiency. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[82]  H. Kayserili,et al.  A novel semiquantitative polymerase chain reaction/enzyme digestion-based method for detection of large scale deletions/conversions of the CYP21 gene and mutation screening in Turkish families with 21-hydroxylase deficiency. , 2003, The Journal of clinical endocrinology and metabolism.

[83]  R. Azziz,et al.  A multicenter study of women with nonclassical congenital adrenal hyperplasia: relationship between genotype and phenotype. , 2000, Molecular genetics and metabolism.

[84]  I. Hughes,et al.  Growth and body proportions in congenital adrenal hyperplasia. , 1989, Archives of disease in childhood.

[85]  A. Lucky,et al.  Adrenal androgen hyperresponsiveness to adrenocorticotropin in women with acne and/or hirsutism: adrenal enzyme defects and exaggerated adrenarche. , 1986, The Journal of clinical endocrinology and metabolism.

[86]  P. White,et al.  Structure of human steroid 21-hydroxylase genes. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[87]  F. Conte,et al.  The effect of long acting glucocorticoids on menstrual abnormalities in patients with virilizing congenital adrenal hyperplasia. , 1978, The Journal of clinical endocrinology and metabolism.

[88]  F. Baronio,et al.  CYP21 genotype, adult height, and pubertal development in 55 patients treated for 21-hydroxylase deficiency. , 2003, The Journal of clinical endocrinology and metabolism.